Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones. J Ocul Pharmacol Ther. 2012 Feb; 28(1):3-11.